Key result
Myocardial injury (hs-troponin > 11.6) in patients recently recovered from COVID-19 was associated with significantly lower ejection fraction and left ventricular global longitudinal strain (P<0.001).
Why the study?
COVID-19 can affect the cardiovascular system, and 2D speckle tracking echocardiography can diagnose early subclinical myocardial dysfunction linked to elevated cardiac biomarkers.
Does 2D speckle tracking echocardiography detect subclinical LV dysfunction in patients recently recovered from COVID-19 with myocardial injury?
Observational (n=100)
No
Does 2D speckle tracking echocardiography detect subclinical LV dysfunction in patients recently recovered from COVID-19 with myocardial injury?
p-value: p=< 0.001
In patients recently recovered from COVID-19, those with elevated hs-troponin have significantly lower LV global longitudinal strain, suggesting 2D-STE is useful for detecting subclinical myocardial dysfunction.
Should not yet change post-COVID monitoring; hypothesis-generating for 2D-STE in myocardial injury, needs prospective validation.
Background: The COVID-19 infection has firmly established itself as a pandemic that can affect many body systems, including the cardiovascular system.2D speckle tracking echocardiography (2D-STE) can diagnose early subclinical myocardial dysfunction, as many studies have reported an inverse correlation of increased cardiac biomarkers level with global longitudinal strain (GLS) values among COVID-19 patients. Aim: This study assessed the global Left ventricular strain using speckle tracking echocardiography in patients recently recovered from COVID-19 infection. Patients and methods: This study was done in Benha University Hospital from June 2022 to January 2023 and included 100 patients who had positive COVID-19 diagnosis proved by positive polymerase chain reaction (PCR) test of the nasopharyngeal swab within 30 ±5 days. Results: Patients were classified according to the upper laboratory limit of the hs-troponin (11.6) into two groups; with myocardial injury (hs-troponin > 11.6) and without myocardial injury (hs-troponin ≤ 11.6). Patients with myocardial injury had significantly lower EF and LVGLS (P < 0.001). No significant differences were observed regarding ECG abnormality, D-dimer, and TLC. Moreover, LVGLS showed significant negative correlations with age (P < 0.001), hs-troponin (P = 0.013), and D-dimer (P = 0.013). In contrast, it showed a significant positive correlation with EF (P < 0.001), and no significant correlation was observed with TLC (P = 0.408). Conclusion: Serial measurements of cardiac troponin and LVGLS following recovery from COVID‐19 infection has an incremental prognostic value and can be used to evaluate the progression of sub‐clinical LV dysfunction.
No takes yet. Share an insight, caveat, or question.
Abdelrahman et al. (2023) conducted an observational in COVID-19 (n=100). Myocardial injury (hs-troponin > 11.6) vs. No myocardial injury (hs-troponin ≤ 11.6) was evaluated on Ejection fraction and left ventricular global longitudinal strain (p=< 0.001). Myocardial injury (hs-troponin > 11.6) in patients recently recovered from COVID-19 was associated with significantly lower ejection fraction and left ventricular global longitudinal strain (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: